Category business

Business Wire India

 

Multi-Color Corporation (“MCC” or the “Company”) today announced the successful completion of the Company’s financial restructuring process and emergence from its prepackaged Chapter 11 process.

 

The Company’s prepackaged restructuring reduced net debt by approximately $3.8 billion, reduced annualized cash interest expense by more than $330 million, and extended long-term debt maturities to 2033. More than 99% of voting stakeholders voted to accept MCC’s Plan of Reorganization. Upon emergence, MCC also received a significant $889 million new common and preferred equity investment from CD&R and a group of MCC’s existing secured lenders to support MCC’s long-term growth and investment.

 

 

“Today marks a significant milestone for MCC, as well as our customers, teammates, and partners who have supported us throughout this process,” said Hassan Rmaile, President and Chief Executive Officer of MCC. “Over the last several months, we continued to diligently serve and win clients, sharpened our operations, and now – with a significantly stronger balance sheet – we have the financial foundation needed to accelerate investing in the capabilities that make us the global partner of choice for innovative, premium labeling solutions across verticals. We enter this next chapter focused on driving profitable growth, ramping operational excellence, and investing in our people and culture as we work to deliver sustainable long-term value for all stakeholders.”

 

 

With the financial restructuring completed, CD&R remains MCC’s majority owner. CD&R is joined by a certain number of MCC’s existing lenders as minority equity holders.

 

 

Additional Information
For more information on MCC’s restructuring, including access to Court documents, please visit www.veritaglobal.net/MCC. Stakeholders with questions can contact Verita Global, the Company’s claims and noticing agent, at (866) 967-1788 (U.S./Canada toll free) or +1 (310) 751-2688 (International) or submit an inquiry to www.veritaglobal.net/MCC/inquiry.

 

 

Advisors
Kirkland & Ellis LLP and Cole Schotz P.C. are serving as legal counsel, Evercore Group L.L.C. is serving as investment banker, AlixPartners, LLP is serving as financial advisor, and FGS Global is serving as strategic communications advisor to the Company. Quinn Emanuel Urquhart & Sullivan LLP is serving as special counsel to LABL, Inc. Debevoise & Plimpton LLP and Latham & Watkins LLP are serving as legal counsel to CD&R, and Moelis & Company LLC is serving as its financial advisor. Milbank LLP and PJT Partners serve as legal counsel and financial advisor, respectively, to the ad hoc group of secured creditors.

 

 

About MCC
Multi-Color Corporation (MCC) is a global leader in prime label solutions, providing innovative and sustainable solutions to some of the world’s most recognizable brands across a broad range of consumer-oriented end categories. MCC is committed to delivering the world’s best label solutions for their customers to build their brands and add value to the communities in which they operate.

 

 

Forward-Looking Statements
This press release contains certain forward-looking statements with respect to the financial condition, results of operations and business of MCC and its subsidiaries and certain plans and objectives with respect thereto. These forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements often use words such as “anticipate”, “target”, “expect”, “enable”, “estimate”, “intend”, “plan”, “goal”, “believe”, “hope”, “aims”, “continue”, “will”, “may”, “should”, “would”, “could”, or other words of similar meaning. These statements are based on assumptions and assessments made by the Company and its perception of historical trends, current conditions, future developments and other factors. By their nature, forward-looking statements involve risk and uncertainty, because they relate to events and depend on circumstances that will occur in the future and the factors described in the context of such forward-looking statements in this document could cause actual results and developments to differ materially from those expressed in or implied by such forward looking statements. Although it is believed that the expectations reflected in such forward-looking statements are reasonable, no assurance can be given that such expectations will prove to have been correct, and you are therefore cautioned not to place undue reliance on these forward-looking statements which speak only as at the date of this document. The Company does not assume any obligation to update or correct the information contained in this document (whether as a result of new information, future events or otherwise), except as may be required by applicable law. There are several factors which could cause actual results to differ materially from those expressed or implied in forward-looking statements.

 

 

Among the factors that could cause actual results to differ materially from those described in the forward-looking statements are changes in the global, political, economic, business, competitive, market, supply chain, and regulatory forces, future exchange and interest rates, changes in tax rates and any future business combinations or dispositions, uncertainties and costs related to the RSA and the Chapter 11 process, including, among others, potential adverse effects of the Chapter 11 process on the Company’s liquidity and results of operations, including with respect to its relationships with its customers, distribution partners, suppliers, and other third parties; employee attrition and the Company’s ability to retain senior management and other key personnel due to the distractions and uncertainties inherent in the Chapter 11 process; the impact of any cost reduction initiatives; any other legal or regulatory proceedings; the Company’s ability to obtain operating capital, including complying with the restrictions imposed by the terms and conditions of any debtor-in-possession financing, such as the financing mentioned herein; and the risk that any plan of reorganization resulting therefrom may not be implemented at all. Please see the Amended Joint Prepackaged Plan of Reorganization of Multi-Color Corporation and its Debtor Affiliates Pursuant to Chapter 11 of the Bankruptcy Code [Docket No. 754] and the Disclosure Statement Relating to the Joint Prepackaged Plan of Reorganization of Multi-Color Corporation and its Debtor Affiliates Pursuant to Chapter 11 of the Bankruptcy Code [Docket No. 18], for additional considerations and risk factors associated with the company’s Chapter 11 process. Nothing in this press release is intended as a profit forecast or estimate for any period and no statement in this press release should be interpreted to mean that the financial performance for the Company for the current or future financial years would necessarily match or exceed its historical results. Further, this press release is not intended to and does not constitute and should not be construed as, considered a part of, or relied on in connection with any information or offering memorandum, security purchase agreement, or offer, invitation or recommendation to underwrite, buy, subscribe for, otherwise acquire, or sell any securities or other financial instruments or interests or any other transaction.

 

 

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260511970460/en/

 

Business Wire India

 

Elliptic, the global leader in digital asset decisioning, today announced the closing of a $120 million Series D fundraise led by One Peak, with participation from Nasdaq Ventures, Deutsche Bank and the British Business Bank. The round values Elliptic at $670 million.

 

These investors are among the most consequential institutions in global finance, together responsible for trillions in daily market activity, and they have placed their confidence in Elliptic. It is a signal about where the financial system is heading and who is trusted to underpin it, with Elliptic screening more of the global on-chain economy than any other private sector provider.

 

 

The fundraise will accelerate Elliptic’s mission to deliver the enterprise-grade on-chain analytics for the world’s largest and most demanding banks, fintechs, government agencies and crypto and payments companies in the world.

 

 

“As digital assets become more embedded in the global financial system, institutions need trusted infrastructure to manage compliance and risk at scale. Elliptic’s platform plays an important role in providing that infrastructure, helping firms navigate digital asset adoption with confidence and integrity,” said Gary Offner, Senior Vice President, Head of Nasdaq Ventures.

 

 

“The sustainable growth of digital assets depends on strong, institutional-grade risk and compliance foundations. For Deutsche Bank, these frameworks are critical to supporting the responsible development of the digital asset ecosystem and reinforcing trust as the market evolves. Our investment in Elliptic reflects our focus on strengthening these foundations,” said Sabih Behzad, Global Head of Digital Assets & Currencies Transformation, Deutsche Bank.

 

 

Over a decade of proprietary data, built for the AI-native age

 

 

Elliptic was first to bring AI-native compliance to enterprise scale in 2025, not as a feature, but as a fundamentally different way to run compliance operations. Today’s Series D funding will extend that lead. Elliptic has a structural advantage because of its data: founded in 2013, the company has spent over a decade building the deepest, most comprehensive proprietary dataset in the industry, spanning 65+ blockchains and refined through continuous collection and labelling of assets and entities.

 

 

Built on that foundation, Elliptic’s data and intelligence platform processes more contextual information per transaction than any competitor, enabling automated triage, faster decisions and significantly lower cost per investigation. The result is a compliance operation that can do more with less: alerts resolved in minutes not hours, human judgement reserved for where it genuinely matters, and the cost of compliance that falls as volume grows. This is what compliance teams at the world’s largest exchanges and financial institutions are up against. The promise of AI only holds if the data underneath it does too. Elliptic has spent thirteen years making sure it does.

 

 

Charlotte Lawrence, Managing Director of Direct Equity, British Business Bank said, “As institutional adoption of digital assets accelerates, the demand for scalable compliance solutions has never been higher. Elliptic pioneered the use of blockchain analytics to meet this challenge and has cemented its status as a global leader, screening over 1 billion transactions a week for 700+ customers in 30 countries. This investment also proves the British Growth Partnership is doing exactly what it was built to do: unlocking the explosive growth of UK technology scale-ups to deliver long term value for our pension funds.”

 

 

Stablecoins and tokenized assets are becoming foundational to global finance

 

 

Stablecoins and tokenized assets are no longer at the periphery of financial innovation. They are becoming the infrastructure through which value moves globally. In 2025, stablecoins processed $33 trillion in transactions¹, for the exchanges and crypto-native businesses that process the majority of this volume, real-time compliance at scale is not a future requirement, it is an operational necessity today.

 

 

Now we are seeing structural adoption driven by institutions, payments firms and corporate treasury operations building directly on digital asset rails. Elliptic provides the intelligence infrastructure to do so safely, at speed and ahead of regulatory expectations.

 

 

“One Peak invests in category leaders and the signal we trust most is what customers say. We spoke to leading institutions from across all segments of the market, and they spoke with one voice: Elliptic is the leader in digital asset compliance, built on the industry’s most robust proprietary data, and it’s that data advantage that makes their AI genuinely market leading. Elliptic is the essential infrastructure for how stablecoins and tokenized assets move through the global financial system. That customer verdict is what drove our investment,” commented Humbert de Liedekerke Beaufort, Founding Partner, One Peak.

 

 

Real-time compliance for the future of on-chain finance

 

 

Two thirds of global crypto volume is transacted on exchanges that already rely on Elliptic, a foundation that now serves as the compliance backbone as those same assets move into traditional finance. Compliance at enterprise scale is an infrastructure problem for the exchanges handling billions in daily crypto volume and the financial institutions moving on chain alike. Elliptic is built to address this at every point of that journey. By powering Elliptic’s data and intelligence platform and AI-native compliance solutions with the industry’s deepest data layer, Elliptic enables institutions to monitor continuously and in real time, catching risk before it crystallises and directs human judgement only where it is genuinely needed. Elliptic is the compliance layer that scales without scaling cost, built to grow with the on-chain financial system itself.

 

 

​​”Financial systems are being rebuilt on-chain,” said Simone Maini, CEO of Elliptic. “The institutions leading that transition need an on-chain analytics partner that matches their scale, their sophistication, and their ambition. The participation of Nasdaq Ventures, Deutsche Bank, One Peak and the British Business Bank, and the continued confidence of AlbionVC, Evolution Equity Partners and J.P. Morgan is a clear signal of their belief in us as market leaders. We built Elliptic for exactly this moment, and this funding lets us move faster to meet it.”

 

 

About Elliptic

 

 

Elliptic is the leader in digital asset decisioning, we have built the most comprehensive platform for efficiently extracting cryptoasset data and intelligence across blockchains with the greatest accuracy.

 

 

Our platform’s unrivalled uptime, scalability, depth and breadth of our data and intelligence means exacting organizations choose Elliptic for their compliance, risk management, intelligence operations and blockchain infrastructure needs.

 

 

Founded in 2013, Elliptic is headquartered in London with offices in New York, Washington D.C., Miami, Dubai, Singapore and Tokyo. To learn more, visit www.elliptic.co and follow us on LinkedIn and X.

 

 

¹https://www.bloomberg.com/news/articles/2026-01-08/stablecoin-transactions-rose-to-record-33-trillion-led-by-usdc

 

 

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260512331518/en/

 

Business Wire India

 

• FY2025 Pipeline Successes Set the Stage for Pivotal Product Launches
• Achieved Latest FY2025 Management Guidance
• Takeda is Entering a New Era & Transforming for Growth Acceleration

 

Takeda (TOKYO:4502/NYSE:TAK) today announced financial results for the fiscal year 2025 (period ended March 31, 2026). The Company delivered solid results in line with its latest FY2025 Management Guidance, reflecting strong OPEX savings, mitigating revenue headwinds while continuing to invest in future growth.

 

Key Highlights for FY2025

 

 

• Revenue decreased by 1.7% YoY at actual exchange rates (AER), resulting from the loss of exclusivity for VYVANSE® which was partially mitigated by Growth and Launch Products. On a Core basis, Revenue decreased by 2.6% at Constant Exchange Rate (CER).
• Core Operating Profit increased by 0.8% YoY at AER and declined by 0.9% at CER, protected by OPEX savings, while still investing for growth.
• Reported Operating Profit increased by 19.3% YoY at AER, also reflecting a step-down in amortization expenses for VYVANSE and lower restructuring expenses.
• Core EPS increased by 5.2% YoY at AER and by 3.1% at CER, while reported EPS increased by 78.1% YoY.
• Adjusted Free Cash Flow amounted to JPY 684.5 billion, in line with forecast, and the Company ended fiscal year with strong cash balance.
• Delivered key milestones for oveporexton, rusfertide, and zasocitinib, with positive Phase 3 readouts; completed regulatory submissions for oveporexton and rusfertide, and launch preparations underway.

 

Takeda Chief Executive Officer (CEO)-elect, Julie Kim, commented:
“FY2025 was a pivotal year, validating the strength of our execution against demanding development and regulatory milestones, the resilience of our commercial portfolio and our strong position with three major launches planned in the next 12 months and the most robust late-stage pipeline in our history. Our growth roadmap is built around two strategic horizons: transforming for growth through near-term launches and strengthening competitiveness and accelerating growth by transitioning to a new cohort of blockbuster brands, together positioning us for long-term profitable growth and patient impact.”

 

Takeda Chief Financial Officer, Milano Furuta, commented:
“In FY2025, despite topline headwinds, we delivered solid profit and cash flow through disciplined cost control, while directing growth investment toward new product launches and the pipeline. In FY2026, we will continue to focus on transforming operations and protecting profitability while delivering successful launches and advancing our pipeline. Strong cash flow generation and deleveraging will support long-term investment for growth acceleration and ensure competitive returns for our shareholders.”

 

 

Full-year FY2026 Forecast and Guidance
Based on the current business outlook and planned investment profile, Takeda issued the following FY2026 forecast and management guidance.

 

 

(Billion yen, except percentages and per share amounts)
Item		FY2026 FORECAST		FY2026   MANAGEMENT GUIDANCE   Core Change at CER   (Non-IFRS)
Revenue		4,640.0		—
Core Revenue (Non-IFRS)		4,640.0		Low- single digit % decline
Operating Profit		420.0		—
Core Operating Profit (Non-IFRS)		1,160.0		5% ~ 8% decline
Net Profit		166.0		—
EPS (Yen)		104		—
Core EPS (Yen (Non-IFRS)		472		Mid-teens % decline
Adjusted Free Cash Flow (Non-IFRS)		650.0-750.0		—
Annual Dividend per Share (Yen)		204		—

 

Pipeline Achievements Set the Stage for Future Growth
Our three leading late-stage assets are positioned for regulatory approvals in the U.S. and other geographies in FY2026-2027. We expect this will be a pivotal period for launches and investment with clear near-term wins and proof points over the next 12–24 months.

 

oveporexton:

 

 

• Oveporexton is potentially a first-of-its-kind orexin agonist designed to address the underlying orexin deficiency that causes narcolepsy type 1.
• Granted Priority Review by the U.S. FDA, Takeda is preparing for a U.S. commercial launch for oveporexton in the second half of 2026 and has also completed regulatory filings in Japan and China.

 

rusfertide:

 

• Rusfertide is a potential first‑in‑class hepcidin mimetic that has demonstrated rapid, stable, and durable hematocrit control in patients with polycythemia vera, or PV, and has the potential to shift the standard of care in this blood cancer.
• Granted Priority Review by the U.S. FDA, Takeda is preparing for a U.S. commercial launch for rusfertide in the second half of 2026.

 

zasocitinib:

 

• Zasocitinib is poised to be a leading oral treatment option for psoriasis patients with the potential to significantly expand the oral segment in a growing psoriasis market.
• Takeda is making decisive investments to support a planned regulatory filing in 2026 and a commercial launch in the first half of 2027.

 

FINANCIAL HIGHLIGHTS for FY2025 Ended March 31, 2026
(Billion yen, except percentages and per share amounts)
Item		FY2025   (Billion JPY)		FY2024   (Billion JPY)		YoY Growth   (AER)
Revenue		4,505.7		4,581.6		-1.7%
Operating Profit		408.8		342.6		+19.3%
Margin		9.1%		7.5%		+1.6pp
Net Profit		191.8		107.9		+77.7%
EPS (Yen)		122		68		+78.1%
Operating Cash Flow		1,041.4		1057.2		-1.5%
Adjusted Free Cash Flow (Non-IFRS)		684.5		769.0		-11.0%

Core (Non-IFRS)
(Billion yen, except percentages and per share amounts)
Item		FY2025   (Billion JPY)		FY2024   (Billion JPY)		YoY Growth   (AER)		YoY Growth   (CER)
Revenue		4,505.7		4,579.8		-1.6%		-2.6%
Operating Profit		1,172.5		1,162.6		+0.8%		-0.9%
Margin		26.0%		25.4%		+0.6pp		—
Net Profit		814.1		775.6		+5.0%		+2.9%
EPS (Yen)		517		491		+5.2%		+3.1%

Capital Allocation and Shareholder Returns
Takeda maintains a disciplined capital allocation framework that prioritizes investments in new launches and R&D innovation to drive growth and enables the company to deliver returns to shareholders under its progressive dividend policy. In FY2025, the proposed annual dividend was JPY 200 per share, and year-end adjusted net debt/adjusted EBITDA was 2.6x.

 

Additional Information About Takeda’s FY2025 Results
Takeda will host a conference call for investors and analysts on Wednesday, May 13, 2026, at 7:00 PM JST / 6:00 AM EDT to discuss its full-year 2025 financial results.

 

 

A live webcast of the conference call, along with presentation materials, will be available on the investor relations section of Takeda’s website at www.takeda.com/investors. The presentation will contain further details on Takeda’s FY2025 results, commercial progress, pipeline updates, and other financial information, including key assumptions for the FY2026 forecast and definitions of non-IFRS measures.

 

 

About Takeda
Takeda is focused on creating better health for people and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines. Together with our partners, we aim to improve the patient experience and advance a new frontier of treatment options through our dynamic and diverse pipeline. As a leading values-based, R&D-driven biopharmaceutical company headquartered in Japan, we are guided by our commitment to patients, our people and the planet. Our employees in approximately 80 countries and regions are driven by our purpose and are grounded in the values that have defined us for more than two centuries. For more information, visit https://www.takeda.com.

 

 

Important Notice
For the purposes of this notice, “press release” means this document, any oral presentation, any question and answer session and any written or oral material discussed or distributed by Takeda Pharmaceutical Company Limited (“Takeda”) regarding this press release. This press release (including any oral briefing and any question-and-answer in connection with it) is not intended to, and does not constitute, represent or form part of any offer, invitation or solicitation of any offer to purchase, otherwise acquire, subscribe for, exchange, sell or otherwise dispose of, any securities or the solicitation of any vote or approval in any jurisdiction. No shares or other securities are being offered to the public by means of this press release. No offering of securities shall be made in the United States except pursuant to registration under the U.S. Securities Act of 1933, as amended, or an exemption therefrom. This press release is being given (together with any further information which may be provided to the recipient) on the condition that it is for use by the recipient for information purposes only (and not for the evaluation of any investment, acquisition, disposal or any other transaction). Any failure to comply with these restrictions may constitute a violation of applicable securities laws.

 

 

The companies in which Takeda directly and indirectly owns investments are separate entities. In this press release, “Takeda” is sometimes used for convenience where references are made to Takeda and its subsidiaries in general. Likewise, the words “we”, “us” and “our” are also used to refer to subsidiaries in general or to those who work for them. These expressions are also used where no useful purpose is served by identifying the particular company or companies.

 

 

The product names appearing in this document are trademarks or registered trademarks owned by Takeda, or their respective owners.

 

 

Forward-Looking Statements

 

 

This press release and any materials distributed in connection with this press release may contain forward-looking statements, beliefs or opinions regarding Takeda’s future business, future position and results of operations, including estimates, forecasts, targets and plans for Takeda. Without limitation, forward-looking statements often include words such as “targets”, “plans”, “believes”, “hopes”, “continues”, “expects”, “aims”, “intends”, “ensures”, “will”, “may”, “should”, “would”, “could”, “anticipates”, “estimates”, “projects”, “forecasts”, “outlook” or similar expressions or the negative thereof. These forward-looking statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those expressed or implied by the forward-looking statements: the economic circumstances surrounding Takeda’s global business, including general economic conditions in Japan and the United States and with respect to international trade relations; competitive pressures and developments; changes to applicable laws and regulations, including drug pricing, tax, tariff and other trade-related rules; challenges inherent in new product development, including uncertainty of clinical success and decisions of regulatory authorities and the timing thereof; uncertainty of commercial success for new and existing products; manufacturing difficulties or delays; fluctuations in interest and currency exchange rates; claims or concerns regarding the safety or efficacy of marketed products or product candidates; the impact of health crises, like the novel coronavirus pandemic; the success of our environmental sustainability efforts, in enabling us to reduce our greenhouse gas emissions or meet our other environmental goals; the extent to which our efforts to increase efficiency, productivity or cost-savings, such as the integration of digital technologies, including artificial intelligence, in our business or other initiatives to restructure our operations will lead to the expected benefits; and other factors identified in Takeda’s most recent Annual Report on Form 20-F and Takeda’s other reports filed with the U.S. Securities and Exchange Commission, available on Takeda’s website at: https://www.takeda.com/investors/sec-filings-and-security-reports/ or at www.sec.gov. Takeda does not undertake to update any of the forward-looking statements contained in this press release or any other forward-looking statements it may make, except as required by law or stock exchange rule. Past performance is not an indicator of future results and the results or statements of Takeda in this press release may not be indicative of, and are not an estimate, forecast, guarantee or projection of Takeda’s future results.

 

 

Financial information and Non-IFRS Measures

 

 

Takeda’s financial statements are prepared in accordance with International Financial Reporting Standards (“IFRS”).

 

 

This press release and materials distributed in connection with this press release include certain financial measures not presented in accordance with IFRS, such as Core Revenue, Core Operating Profit, Core Net Profit for the year attributable to owners of the Company, Core EPS, Constant Exchange Rate (“CER”) change, Net Debt, Adjusted Net Debt, EBITDA, Adjusted EBITDA, Free Cash Flow and Adjusted Free Cash Flow. Takeda’s management evaluates results and makes operating and investment decisions using both IFRS and non-IFRS measures included in this press release. These non-IFRS measures exclude certain income, cost and cash flow items which are included in, or are calculated differently from, the most closely comparable measures presented in accordance with IFRS. Takeda’s non-IFRS measures are not prepared in accordance with IFRS and such non-IFRS measures should be considered a supplement to, and not a substitute for, measures prepared in accordance with IFRS (which we sometimes refer to as “reported” measures). Investors are encouraged to review the definitions and reconciliations of non-IFRS measures to their most directly comparable IFRS measures, which are in the Financial Appendix appearing at the end of our FY2025 Q4 investor presentation (available at www.takeda.com/investors).

 

 

Medical information

 

 

This press release contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, in different dosages, or in different strengths. Nothing contained herein should be considered a solicitation, promotion or advertisement for any prescription drugs including the ones under development.

 

 

Please refer to slide 14 of Takeda’s FY2025 Q4 investor presentation (available at https://www.takeda.com/investors/financial-results/quarterly-results/) for the definition of Growth & Launch Products.

 

 

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260510786927/en/

 

Business Wire India

Hyderabad-based Bhagyanagar India Limited (BSE: 512296, NSE: BHAGYANGR) has reported strong financial growth for FY 2025–26, with revenue increasing 46% year-on-year to INR 2,377 crore and profit after tax rising 258% to INR 50 crore. Backed by rising demand across infrastructure, renewable energy, electric vehicles, and industrial manufacturing, the company has outlined a long-term roadmap targeting INR 5,000 crore in revenue by FY 2029–30.

The growth comes amid increasing demand for copper across sectors such as renewable energy, electric mobility, power infrastructure, telecom, and data centres, where copper remains a critical industrial material. The company’s market capitalization has also crossed the INR 1,000 crore mark over the past year, reflecting increased investor interest and business momentum.

Financial Highlights — FY 2025–26 (Consolidated)

Figures in INR Crore. Source: Regulatory filings with NSE and BSE.

Particulars	FY 2025–26	FY 2024–25	Growth
Revenue (Turnover)	INR 2,377.83 Cr	INR 1,625.61 Cr	46%
Operational EBITDA	INR 106.14 Cr	INR 37.02 Cr	187%
Profit Before Tax (PBT)	INR 67.51 Cr	INR 18.68 Cr	261%
Profit After Tax (PAT)	INR 50.17 Cr	INR 14.02 Cr	258%

 

Expansion Roadmap

Bhagyanagar India and its leadership, headed by Devendra Surana, have outlined a long-term growth roadmap focused on expanding the company’s presence within India’s non-ferrous metals sector, which includes:

• Capacity expansion to 45,000 metric tonnes: The company has already achieved 35,000 MT of production capacity as of March 2026, making the next phase of expansion a clear and credible strategic progression.
• INR 40 crore capital investment: Committed to manufacturing infrastructure over the next two years, directly backing the capacity ramp-up.
• Corporate restructuring via NCLT-admitted demerger scheme: An NCLT-admitted demerger scheme under which Bhagyanagar India’s copper manufacturing business will be carved out into Tieramet Limited — a standalone, independently listed company — creating a cleaner corporate structure and giving shareholders direct equity exposure to one of India’s most strategically positioned copper businesses.
• INR 5,000 crore revenue target by FY 2029–30: Anchored by the ongoing capacity ramp-up and the convergence of powerful demand drivers — AI data centre build-outs, utility-scale renewable energy, electric vehicle adoption, and India’s accelerating push toward industrial self-reliance.

Competitive Strengths

Bhagyanagar India’s growth strategy continues to be supported by:

• 40-year unblemished track record: Not a single loss-making quarter in the company’s history or a single day’s delay in any of its obligations stands out as a rare distinction in a cyclical sector, and a testament to the durability and strong corporate governance norms of its business model.
• Deep OEM relationships: Long-standing supplier and customer ties with major industrial names, backed by hands-on leadership.
• Sustained financial momentum: Seven consecutive quarters of profit growth, with operating leverage now visibly translating into margin expansion across the P&L.
• Powerful sectoral tailwinds: India’s energy transition, EV adoption, AI infrastructure build-out, and the country’s broader manufacturing-led growth story — all of which run on copper.

Commenting on the company’s performance and long-term vision, Shri Devendra Surana, Managing Director, Bhagyanagar India Limited, said: “The future runs on copper, and Bhagyanagar India has been contributing to that future for over four decades. As India continues to witness growth across infrastructure, renewable energy, electric mobility, and industrial manufacturing, we remain focused on expanding our capabilities, strengthening operational efficiencies, and building a sustainable growth platform within India’s non-ferrous metals sector.”

He added: “With our NCLT-admitted demerger scheme progressing on schedule, our capacity expansion to 45,000 MT well underway, and an INR 40 crore capex commitment firmly in place, we are on a clear and well-funded path toward our INR 5,000 crore revenue target by FY 2029–30.”

Business Wire India

 

1Q 2026

 

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260512320157/en/

 

 

 

• Total business volume at 53.0 billion euros, an internal growth of 3.5 percent¹. This was driven by a strong development in Property-Casualty and Asset Management
• Operating profit rises 6.6 percent and reaches a record level of 4.5 billion euros
• Shareholders’ core net income advances by 48.4 percent to 3.8 billion euros, impacted by the sale of the stakes in our Indian Joint Ventures. Underlying growth, which adjusts for the sale effects and offsetting measures, is strong at 7 percent²
• Core earnings per share grow 50.7 percent and reach 9.96 euros. Adjusted for the above-mentioned effects, underlying growth is excellent at 9 percent ²
• Annualized core RoE at 24.2 percent, underlying level very strong at 18 percent ²
• Solvency IIratio³ increases by 2 percentage points to 221 percent⁴. Capital generation was strong

Outlook & other

 

• Allianz is on track to achieve its full-year operating profitoutlook of 17.4 billion euros, plus or minus 1 billion euros⁵
• Share buy-back program of up to 2.5 billion euros announced on February 25, 2026 underway; 0.3 billion euros completed in 1Q 2026

 

CEO comment

 

“Allianz delivered a record operating profit in the first quarter of 2026 – a testament to the strength of our fundamentals and the effectiveness of our customer-centered strategy.

 

 

We remain disciplined in our delivery as we work to expand affordable protection and retirement for more people, harnessing the potential of AI to serve them in an even more efficient and personalized way.

 

 

By rigorously combining technological advancements with our expertise and empathy to meet customer needs, we create a unique value proposition and opportunities for everyone who puts their trust into Allianz.“

 

 

– Oliver Bäte, Chief Executive Officer of Allianz SE

 

 

FINANCIAL HIGHLIGHTS

 

 

Allianz Group: Strong start to 2026

 

 

Key performance indicator

1Q 2026

Change vs prior year

 

Total business volume (€ bn); change shows internal growth		53.0		3.5%
Operating profit (€ mn)		4,517		6.6%
Shareholders’ core net income (€ mn)		3,785		48.4%
Core return on equity (annualized) (%) 6		24.2		6.1%-p
Solvency II ratio (%) 6		221		2%-p

CFO comment

 

“Allianz’s first-quarter performance reflects the quality of our diversified portfolio and the rigorous execution of our strategic priorities.

 

 

We built on the momentum of an excellent 2025, achieving profitable growth and a record operating profit of 4.5 billion euros. These results demonstrate our ability to create sustainable value for our customers and shareholders, even in a demanding operating environment.

 

 

We remain focused on the delivery of our ambitions and affirm our full-year outlook with confidence.”

 

 

– Claire-Marie Coste-Lepoutre, Chief Financial Officer of Allianz SE

 

 

Our total business volume amounted to 53.0 billion euros (1Q 2025: 54.0 billion euros). Internal growth, which excludes the effects of foreign-currency translation as well as acquisitions and divestments, was 3.5 percent. The Property-Casualty segment was the main contributor with strong business growth also in Asset Management.

 

 

Operating profit rose 6.6 percent to a record level of 4.5 (4.2) billion euros and reached 26 percent of our full-year outlook midpoint. This reflects a strong development of our Property-Casualty and Asset Management segments. The performance of our Life/Health segment was resilient in a volatile market environment.

 

 

Shareholders’ core net income advanced 48.4 percent to 3.8 (2.6) billion euros. Adjusted for the effects of the sale of the stakes in our Indian Joint Ventures and offsetting measures, shareholders’ core net income advanced strongly by 7 percent², almost exclusively driven by a higher operating profit.

 

 

Core earnings per share (EPS)⁷ amounted to 9.96 (6.61) euros, an increase of 50.7 percent. Adjusted for the above-mentioned effects, growth was excellent at 9 percent², the top-end of our 7-9 percent CAGR target for the 2025-2027 strategic cycle.

 

 

Allianz delivered an annualized core return on equity (RoE)⁷ of 24.2 percent in 1Q 2026 (12M 2025: 18.1 percent). Adjusted for the above-mentioned effects, our annualized core return on equity was at a very strong level of 18 percent².

 

 

This performance was achieved while we further strengthened our capitalization. Our Solvency II ratio reached 221 percent, an increase of 2 percentage points compared to full-year 2025 (218 percent), supported by strong capital generation.

 

 

Outlook

 

 

Allianz is on track to achieve its full-year outlook of an operating profit of 17.4 billion euros, plus or minus 1 billion euros.

 

 

Other

 

 

The share buy-back program of up to 2.5 billion euros, announced on February 25, 2026, is underway and 0.3 billion euros were completed in the first three months of 2026.

 

 

Property-Casualty insurance: Another record performance

 

 

Key performance indicator

1Q 2026

Change vs prior year

 

Total business volume (€ bn); change shows internal growth		28.3		6.8%
Operating profit (€ mn)		2,411		11.1%
Combined ratio (%)		91.0		-0.9%-p
Loss ratio (%)		67.3		-0.4%-p
Expense ratio (%)		23.7		-0.5%-p

Core messages Property-Casualty insurance 1Q 2026

Sustained strong internal growth, in particular in retail

Highest quarterly operating profit ever, reaching 27 percent of our full-year outlook midpoint

Combined ratio excellent; strong underwriting performance and very good expense ratio

In 1Q 2026,total business volume reached 28.3 (1Q 2025: 27.0) billion euros. Internal growth was strong at 6.8 percent, sustaining the good momentum from last year. Allianz maintained a successful balance of growing its business while keeping underwriting discipline.

 

The record operating profit of 2.4 (2.2) billion euros marked a successful start to the year, reaching 27 percent of our full-year outlook midpoint. Operating profit advanced 11.1 percent, entirely driven by a higher insurance service result.

 

 

The combined ratio improved to an excellent level of 91.0 percent (91.8 percent), ahead of our full-year outlook of 92 to 93 percent. This development was supported by the loss ratio and expense ratio.

 

 

The loss ratio was at a strong level of 67.3 percent (67.7 percent), an improvement of 0.4 percentage points. The expense ratio developed favorably by 0.5 percentage points to 23.7 percent, reflecting top-line growth and productivity gains.

 

 

The retail⁸ business sustained its momentum and delivered strong internal growth of 8 percent. The segment’s combined ratio further improved to 91.4 percent (91.8 percent).

 

 

In the commercial⁹ business, internal growth of 6 percent was good. The segment achieved an excellent combined ratio of 90.3 percent (91.7 percent).

 

 

Life/Health insurance: Resilient performance

 

 

Key performance indicator

1Q 2026

Change vs prior year

 

PVNBP (€ mn)		23,727		-9.1%
New business margin (%)		5.3		-0.2%-p
VNB (€ mn)		1,260		-12.5%
Operating profit (€ mn)		1,354		-5.1%
Contractual Service Margin (€ bn, eop)		55.4		1.7% 10

Core messages Life/Health insurance 1Q 2026

Value of new business at a good level of 1.3 billion euros, with a high-quality business mix

New business margin of 5.3 percent above our ambition level of at least 5 percent

Operating profit of 1.4 billion euros resilient in a volatile environment

In 1Q 2026, PVNBP, the present value of new business premiums, amounted to a good level of 23.7 (1Q 2025: 26.1) billion euros. Adjusted for foreign currency translation effects and the sale of our stake in UniCredit Allianz Vita, PVNBP reduced only marginally – by 1 percent – from an exceptionally strong prior year level. 91 percent (91 percent) of our new business was generated in our preferred lines of business (capital-efficient products, unit-linked without guarantees, protection & health).

 

The new business margin (NBM) was healthy at 5.3 percent (5.5 percent), ahead of our ambition level of at least 5 percent. The value of new business (VNB) reached a good level of 1.3 (1.4) billion euros. Adjusted for foreign currency translation effects, the sale of our stake in UniCredit Allianz Vita, and exceptional large contracts in Germany in the prior year quarter, VNB remained broadly stable.

 

 

Operating profit remained resilient at 1.4 (1.4) billion euros in a volatile operating environment. Adjusted for foreign currency translation effects as well as the sale of the stakes in our Indian Joint Ventures and in UniCredit Allianz Vita, operating profit was up 3 percent.

 

 

The Contractual Service Margin (CSM) was 55.4 (12M 2025: 55.7) billion euros. Normalized CSM growth was 1.7 percent, supporting our full-year expectations of around 5 percent.

 

 

Asset Management: Excellent organic growth with record 1Q inflows

 

 

Key performance indicator		1Q 2026		Change vs prior year
Operating revenues (€ bn); change shows internal growth		2.2		12.7%
Operating profit (€ mn)		857		5.8%
Cost-income ratio (%)		60.4		-0.9%-p
Third-party net flows (€ bn)		45.2		57.6%
Third-party assets under management (€ bn)		2,043		6.7%
Average third-party assets under management (€ bn)		2,041		5.1%

 

Core messages Asset Management 1Q 2026

Assets under management (AUM)-driven revenues grow by 11 percent (F/X adjusted)

Operating profit increases by 15 percent (F/X adjusted)

Record first quarter net inflows of 45 billion euros

In 1Q 2026, operating revenues increased to 2.2 billion euros, an internal growth of 12.7 percent. This was supported by higher AuM-driven revenues, which advanced by 11.1 percent (F/X adjusted), as well as by higher performance fees.

 

Operating profit was strong at 857 (1Q 2025: 811) million euros, up 5.8 percent. Adjusted for foreign currency translation effects, operating profit increased by 15.0 percent. The cost-income ratio (CIR) improved to a very good level of 60.4 percent (61.3 percent), which is ahead of our full-year ambition of less than 61 percent. This development reflects sustained top-line momentum and management actions.

 

 

Third-party assets under management reached a record level of 2.043 trillion euros as of March 31, 2026 (4Q 2025: 1.990 trillion euros; 1Q 2025: 1.914 trillion euros). Very strong net inflows of 45 billion euros were the main contributor. Average third-party assets under management increased to 2.041 trillion euros, 5.1 percent above 1Q 2025.

 

 

FOOTNOTES

 

 

1		Total growth -1.8 percent in 1Q 26.
2		Adjusted for sale of stakes in Indian JVs (net income impact: -0.1 billion euros tax provision in 1Q 25 and 1.1 billion euros gain in 1Q 26) and offsetting measures (net income impact: -0.15 billion euros in 1Q 26).
3		Solvency II ratio / Solvency II capitalization ratio: ratio that expresses the capital adequacy of a company by comparing own funds to SCR. This applies to all information related to the Solvency II ratio in this document.
4		Based on quarterly dividend accrual; additional accrual to reflect FY dividend would impact Solvency II capitalization ratio by -11%-p as of March 31, 2026. This applies to all information regarding the Solvency II capitalization ratio in this document.
5		As always, natural catastrophes and adverse developments in the capital markets, as well as factors stated in our cautionary note regarding forward-looking statements may severely affect the operating profit and/or net income of our operations and the results of the Allianz Group.
6		Change versus full-year 2025.
7		Core EPS and core RoE calculation based on shareholders‘ core net income.
8		Retail including SME and Fleet. This applies to all information related to retail in this document.
9		Commercial including large Corporate, MidCorp, credit insurance, internal and 3rd party R/I. This applies to all information related to commercial in this document.
10		Normalized CSM growth compared to December 31, 2025.

 

1Q 2026 RESULTS TABLE

 

Allianz Group – key figures 1st quarter 2026
						1Q 2026		1Q 2025		Delta
Total business volume				€ bn		53.0		54.0		-1.8%
– Property-Casualty				€ bn		28.3		27.0		4.9%
– Life/Health				€ bn		22.6		25.0		-9.6%
– Asset Management				€ bn		2.2		2.1		3.5%
– Consolidation				€ bn		-0.1		-0.1		4.1%
Operating profit / loss				€ mn		4,517		4,238		6.6%
– Property-Casualty				€ mn		2,411		2,170		11.1%
– Life/Health				€ mn		1,354		1,427		-5.1%
– Asset Management				€ mn		857		811		5.8%
– Corporate and Other				€ mn		-114		-165		-30.9%
– Consolidation				€ mn		8		-4		n.m.
Net income				€ mn		3,846		2,581		49.0%
– attributable to non-controlling interests				€ mn		156		158		-1.3%
– attributable to shareholders				€ mn		3,690		2,423		52.3%
Shareholders’ core net income1				€ mn		3,785		2,550		48.4%
Core earnings per share2				€		9.96		6.61		50.7%
Additional KPIs
– Group		Core return on equity3		%		24.2%		18.1%		6.1%	-p
– Property-Casualty		Combined ratio		%		91.0%		91.8%		-0.9%	-p
– Life/Health		New business margin		%		5.3%		5.5%		-0.2%	-p
– Asset Management		Cost-income ratio		%		60.4%		61.3%		-0.9%	-p
						03/31/2026		12/31/2025		Delta
Shareholders’ equity4				€ bn		65.9		62.7		5.1%
Contractual service margin (net)				€ bn		34.9		35.4		-1.3%
Solvency II capitalization ratio5				%		221%		218%		2%	-p
Third-party assets under management				€ bn		2,043		1,990		2.6%
	Please note: The figures are presented in millions of Euros, unless otherwise stated. Due to rounding, numbers presented may not add up precisely to the totals provided and percentages may not precisely reflect the absolute figures.
1_	Presents the portion of shareholders’ net income before non-operating market movements and before amortization of intangible assets from business combinations (including any related income tax effects).
2_	Calculated by dividing the respective period’s shareholders’ core net income, adjusted for net financial charges related to undated subordinated bonds classified as shareholders’ equity, by the weighted average number of shares outstanding (basic core EPS).
3_	Represents the annualized ratio of shareholders’ core net income to the average shareholders’ equity at the beginning and at the end of the period. Shareholders’ core net income is adjusted for net financial charges related to undated subordinated bonds classified as shareholders’ equity. From the average shareholders’ equity, undated subordinated bonds classified as shareholders’ equity, unrealized gains and losses from insurance contracts and other unrealized gains and losses are excluded. Annualized figures are not a forecast for full year numbers. For 1Q 2025, the core return on equity for the respective full year is shown.
4_	Excluding non-controlling interests.
5_	Risk capital figures are group diversified at 99.5% confidence level. Solvency II capitalization ratio is based on quarterly dividend accrual; additional accrual to reflect FY dividend would impact solvency II capitalization ratio by -11%-p as of 31 March 2026.

 

RATING

 

Ratings1		S&P Global		Moody’s		A.M. Best2
Insurer financial strength rating		AA | stable outlook		Aa2 | stable outlook		A+ | stable outlook
Counterparty credit rating		AA | stable outlook		Not rated		aa3 | stable
Senior unsecured debt rating		AA		Aa2 | stable outlook		aa | stable
Subordinated debt rating		A+/A		A1/A34 | stable outlook		aa- / a+ | stable
Commercial paper (short term) rating		A-1+		Prime-1		Not rated

 

1		Includes ratings for securities issued by Allianz Finance II B.V. and Allianz Finance Corporation.
2		A.M. Best’s Rating Reports reproduced on www.allianz.com appear under licence from A.M. Best Company and do not constitute, either expressly or implicitly, an endorsement of Allianz’s products or services. A.M. Best’s Rating Reports are the copyright of A.M. Best Company and may not be reproduced or distributed without the express written consent of A.M. Best Company. Visitors to www.allianz.com are authorised to print a single copy of the rating report displayed there for their own use. Any other printing, copying or distribution is strictly prohibited. A.M. Best’s ratings are under continual review and subject to change or affirmation. To confirm the current rating visit www.ambest.com.
3		Issuer credit rating.
4		Final ratings vary on the basis of the terms.

Related links

 

Media Conference
May 13, 2026, 9:30 AM CEST: YouTube (English language)

 

 

Analyst Conference
May 13, 2026, 2:30 PM CEST: YouTube (English language)

 

 

Results
The results and related documents can be found in the download center.

 

 

Upcoming events

 

 

Financial Results 2Q & 6M 2026
August 7, 2026

 

 

More information can be found in the financial calendar.

 

 

About Allianz

 

 

The Allianz Group is one of the world’s leading insurers and asset managers, active in almost 70 countries and serving around 97 million private and corporate customers*. Our customers benefit from a broad range of personal and corporate insurance services, including property, life and health insurance, as well as assistance services, credit and global business insurance. Recognized for the seventh consecutive year as the number one global insurance brand in Interbrand’s Best Global Brands 2025 ranking, Allianz’s success is built on technology-enabled customer centricity – providing peace of mind, protection, and prevention for our customers and strengthening the resilience of individuals, communities, and societies. We are one of the world’s largest investors, managing around 770 billion euros** on behalf of our insurance customers. Furthermore, our asset managers PIMCO and Allianz Global Investors manage about 2.0 trillion euros** of third-party assets. Thanks to our systematic integration of environmental and social criteria in our business processes and investment decisions, Allianz received an MSCI ESG Rating of AAA (as of March 2026). In 2025, our 156,000 dedicated employees achieved a total business volume of 186.9 billion euros and an operating profit of 17.4 billion euros for our shareholders.

 

 

* As of December 31, 2025. Customer count reflects Allianz customers in consolidated entities that are part of the customer reporting scope only.

 

 

** As of March 31, 2026.

 

 

These assessments are, as always, subject to the disclaimer provided below.

 

 

Cautionary note regarding forward-looking statements

 

 

This document includes forward-looking statements, such as prospects or expectations, that are based on management’s current views and assumptions and subject to known and unknown risks and uncertainties. Actual results, performance figures, or events may differ significantly from those expressed or implied in such forward-looking statements.

 

 

Deviations may arise due to changes in factors including, but not limited to, the following: (i) the general economic and competitive situation in the Allianz’s core business and core markets, (ii) the performance of financial markets (in particular market volatility, liquidity, and credit events), (iii) adverse publicity, regulatory actions or litigation with respect to the Allianz Group, other well-known companies and the financial services industry generally, (iv) the frequency and severity of insured loss events, including those resulting from natural catastrophes, and the development of loss expenses, (v) mortality and morbidity levels and trends, (vi) persistency levels, (vii) the extent of credit defaults, (viii) interest rate levels, (ix) currency exchange rates, most notably the EUR/USD exchange rate, (x) changes in laws and regulations, including tax regulations, (xi) the impact of acquisitions including and related integration issues and reorganization measures, and (xii) the general competitive conditions that, in each individual case, apply at a local, regional, national, and/or global level. Many of these changes can be exacerbated by terrorist activities.

 

 

No duty to update

 

 

Allianz assumes no obligation to update any information or forward-looking statement contained herein, save for any information we are required to disclose by law.

 

 

Other

 

 

The figures regarding the net assets, financial position and results of operations have been prepared in conformity with International Financial Reporting Standards. This Quarterly Earnings Release is not an Interim Financial Report within the meaning of International Accounting Standard (IAS) 34. This is a translation of the German Quarterly Earnings Release of the Allianz Group. In case of any divergences, the German original is binding.

 

 

Privacy Note

 

 

Allianz SE is committed to protecting your personal data. Find out more in our privacy statement.

 

 

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260512320157/en/

 

Business Wire India

FPT AI Factory, in partnership with InFlow and Visa Intelligent Commerce, launches an agent-native commerce platform, enabling access to frontier AI models that fuel AI agents in action. AI agents can dynamically route between models based on cost, latency, or performance. This collaboration allows seamless AI agent workflows to autonomously research, procure, and pay for services while ensuring security and compliance, pioneering the B2AI economy on a global scale.

 

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260512059939/en/

 

 

 

The Dawn of B2AI Commerce

 

B2AI commerce, where AI agents research, negotiate, and complete purchases autonomously, is rapidly moving from concept to production reality. The new horizon is B2AI: an emerging commercial paradigm in which AI agents are the new customer type executing end-to-end procurement workflows under human-defined intent and outcomes.

 

 

Just as cloud infrastructure unlocked the SaaS economy, the agent-native commerce platform is now unlocking the B2AI economy, opening an entirely new commerce market.

 

 

Closing the Loop: The Full B2AI Commerce Stack

 

 

This three-way partnership assembles every layer required for an end-to-end, agent-native transaction.

 

 

InFlow provides B2AI commerce infrastructure for both sides of the transaction. AI agents (buyers) onboard, pay, and transact as discrete customers. Businesses (sellers) onboard, transact with, and monetize agent-driven demand at scale.

 

 

Visa Intelligent Commerce contributes trusted payment credentials and global network access, ensuring every agent-initiated transaction is authenticated, policy-governed, and fully auditable.

 

 

FPT AI Factory serves as the production inference layer, demonstrating the agent-native commerce platform live where AI agents access compute services, execute high-frequency API calls, and generate sustained, programmatic demand.

 

 

Together, the three companies cover the complete transaction stack: identity, payment credentials, and AI compute, making B2AI commerce operational today.

 

 

What This Unlocks for AI Innovators

 

 

For AI agent developers, the partnership removes the friction that has historically kept commerce out of autonomous workflows. Procurement, onboarding, and payment now execute without human-in-the-loop intervention, and every transaction remains traceable and policy-governed in a single, uninterrupted workflow.

 

 

For businesses offering AI services, the platform opens up an entirely new customer segment. AI agents can autonomously onboard and transact on the platform, purchasing inference services, selecting models for corresponding workloads, and sustaining operations without interruption.

 

 

Powering Continuous Agent Workflows on FPT AI Factory

 

 

FPT AI Factory (NVIDIA Cloud Partner) offers robust GPU Cloud, inference-ready AI platforms, and access to more than 25 of the latest AI models via production-ready API, including Nemotron 3 Super, Alpamayo, Qwen 3, and Llama 4, covering the full range of AI workloads from training to deployment. The platform utilizes the latest NVIDIA HGX B300, H200, and H100, fulfilling the rigorous demands of next-generation AI and high-performance computing workloads.

 

 

Within FPT AI Factory, agents dynamically route between models based on cost, latency, or performance requirements, with InFlow handling continuous usage and payment settlement across every inference request. The result is an uninterrupted agentic workflow: agents identify the capability they need, onboard programmatically, transact via Visa Intelligent Commerce’s global payment network, and execute inference at scale, all without a single manual approval step.

 

 

About FPT AI Factory

 

 

FPT AI Factory delivers an all-in-one AI Developer Cloud that combines NVIDIA-accelerated GPU Cloud services, inference-ready AI platforms, and ready-to-use AI applications. Guided by the vision “Build Your Own AI,” FPT AI Factory empowers enterprises, startups, and the tech community with the compute power, model variety, and deployment flexibility to support any AI workload while ensuring optimal price-performance and sovereign AI.

 

 

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260512059939/en/

 

Business Wire India

Rigaku Corporation, a global solution partner in X-ray analytical systems and a group company of Rigaku Holdings Corporation (headquarters: Akishima, Tokyo; CEO: Jun Kawakami; “Rigaku”), announced the expansion of its development of metrology technologies for next-generation semiconductors, leveraging global research environments.

 

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260512888328/en/

 

 

 

As part of this initiative, Rigaku is working with imec, a world-leading semiconductor research and innovation hub headquartered in Belgium, under a three-year development program. Through this effort, Rigaku will advance its core X-ray technologies, including 3D device metrology, high-sensitivity detection of ultrathin films and trace elements, and non-destructive inspection of microscopic defects.

 

As semiconductor devices evolve toward advanced architectures such as Gate-All-Around (GAA) and Complementary FET (CFET)¹, along with increasing memory density, manufacturing processes are becoming more complex. These drives growing demand for highly accurate, non-destructive measurement and inspection technologies to support stable mass production. Rigaku addresses these needs by delivering high-value, differentiated metrology and inspection solutions.

 

 

Key focus areas

 

 

• Advanced logic: Metrology and inspection technologies for CFET devices
• Reticle metrology: Evaluation of photomask degradation used in EUV² lithography
• Advanced wiring and packaging³: Non-destructive inspection technologies
• Advanced memory: Evaluation of nanostructures in 3D DRAM (a next generation memory device)

 

 

Markus Kuhn, Executive Officer and General Manager of Semiconductor Metrology Division of Rigaku, commented, “The serviceable available market (SAM) for Rigaku’s metrology and inspection products in the advanced AI semiconductors is expected to reach approximately US$1 billion by 2030. To address this market growth, Rigaku will continue introducing high‑value, differentiated products, with the goal of achieving a 50% share of this SAM. Strengthening our collaboration with imec will further enhance our competitiveness in high value-added measurement and inspection, supporting medium- to long-term growth.”

 

1 GAA/CFET: Gate-All-Around / Complementary Field-Effect Transistors. A next-generation device architecture in which n-type and p-type transistors are vertically stacked to increase device density beyond nanosheet (GAA) technology.
2 EUV exposure: A core technology for advanced semiconductor manufacturing that enables the formation of ultrafine circuit patterns.
3 Advanced packaging: Packaging technologies that integrate multiple semiconductor chips to enhance performance and reduce power consumption

 

 

About the Rigaku Group

 

 

Since its establishment in 1951, the engineering professionals of the Rigaku group have been dedicated to benefiting society with leading-edge technologies, notably including its core fields of X-ray and thermal analysis. With a market presence in 136 countries and regions and some 2,000 employees from 9 global operations, Rigaku is a solution partner in industry and research analysis institutes. Our overseas sales ratio has reached approximately 70% while sustaining an exceptionally high market share in Japan. Together with our customers, we continue to develop and grow. As applications expand from semiconductors, electronic materials, batteries, environment, resources, energy, life science to other high-tech fields, Rigaku realizes innovations “To Improve Our World by Powering New Perspectives.”
For details, please visit: rigaku-holdings.com/english

 

 

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260512888328/en/